Investigating how EBV infection affects racial differences in IgA nephropathy
IgA Nephropathy: Impact of EBV Infection on Racial Differences
This study is looking at how the Epstein-Barr virus might be linked to IgA nephropathy, a kidney disease, and it wants to understand why this condition affects some racial groups more than others, so if you're a patient, you might be asked to share a blood sample and some health details to help with this important research.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10661504 on NIH RePORTER |
What this research studies
This research explores the relationship between Epstein-Barr virus (EBV) infection and IgA nephropathy, an autoimmune disease that affects kidney function. By analyzing blood samples from patients of different racial backgrounds, the study aims to understand why IgA nephropathy is more common in certain populations compared to others. The researchers will focus on the immune response, particularly the production of specific antibodies, to uncover the underlying mechanisms of this disparity. Patients may be asked to provide blood samples and health information to aid in this investigation.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with IgA nephropathy, especially those from diverse racial backgrounds.
Not a fit: Patients without a diagnosis of IgA nephropathy or those who do not belong to the racial groups being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for IgA nephropathy, particularly for affected racial groups.
How similar studies have performed: Previous research has indicated that viral infections can influence autoimmune diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Mestecky, Jiri F — University of Alabama at Birmingham
- Study coordinator: Mestecky, Jiri F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.